377 related articles for article (PubMed ID: 20039943)
1. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system.
España RA; Oleson EB; Locke JL; Brookshire BR; Roberts DC; Jones SR
Eur J Neurosci; 2010 Jan; 31(2):336-48. PubMed ID: 20039943
[TBL] [Abstract][Full Text] [Related]
2. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration.
España RA; Melchior JR; Roberts DC; Jones SR
Psychopharmacology (Berl); 2011 Mar; 214(2):415-26. PubMed ID: 20959967
[TBL] [Abstract][Full Text] [Related]
3. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1.
Prince CD; Rau AR; Yorgason JT; España RA
ACS Chem Neurosci; 2015 Jan; 6(1):138-46. PubMed ID: 25496218
[TBL] [Abstract][Full Text] [Related]
4. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
Smith RJ; See RE; Aston-Jones G
Eur J Neurosci; 2009 Aug; 30(3):493-503. PubMed ID: 19656173
[TBL] [Abstract][Full Text] [Related]
5. Role of orexin/hypocretin in conditioned sucrose-seeking in rats.
Cason AM; Aston-Jones G
Psychopharmacology (Berl); 2013 Mar; 226(1):155-65. PubMed ID: 23096770
[TBL] [Abstract][Full Text] [Related]
6. Orexin/hypocretin is necessary for context-driven cocaine-seeking.
Smith RJ; Tahsili-Fahadan P; Aston-Jones G
Neuropharmacology; 2010 Jan; 58(1):179-84. PubMed ID: 19591850
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine.
Bernstein DL; Badve PS; Barson JR; Bass CE; España RA
Addict Biol; 2018 Sep; 23(5):1032-1045. PubMed ID: 28971565
[TBL] [Abstract][Full Text] [Related]
8. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
Mahler SV; Smith RJ; Aston-Jones G
Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system.
Jerlhag E; Egecioglu E; Dickson SL; Engel JA
Addict Biol; 2011 Jan; 16(1):82-91. PubMed ID: 20579004
[TBL] [Abstract][Full Text] [Related]
10. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.
LeSage MG; Perry JL; Kotz CM; Shelley D; Corrigall WA
Psychopharmacology (Berl); 2010 Apr; 209(2):203-12. PubMed ID: 20177882
[TBL] [Abstract][Full Text] [Related]
11. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.
Wang B; You ZB; Wise RA
Biol Psychiatry; 2009 May; 65(10):857-62. PubMed ID: 19251246
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling.
Levy KA; Brodnik ZD; Shaw JK; Perrey DA; Zhang Y; España RA
Psychopharmacology (Berl); 2017 Sep; 234(18):2761-2776. PubMed ID: 28667509
[TBL] [Abstract][Full Text] [Related]
13. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers.
Borgland SL; Chang SJ; Bowers MS; Thompson JL; Vittoz N; Floresco SB; Chou J; Chen BT; Bonci A
J Neurosci; 2009 Sep; 29(36):11215-25. PubMed ID: 19741128
[TBL] [Abstract][Full Text] [Related]
14. Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
Zhou L; Smith RJ; Do PH; Aston-Jones G; See RE
Neuropharmacology; 2012 Dec; 63(7):1201-7. PubMed ID: 22971541
[TBL] [Abstract][Full Text] [Related]
15. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Quarta D; Valerio E; Hutcheson DM; Hedou G; Heidbreder C
Neurochem Int; 2010 Jan; 56(1):11-5. PubMed ID: 19737591
[TBL] [Abstract][Full Text] [Related]
16. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.
Cason AM; Smith RJ; Tahsili-Fahadan P; Moorman DE; Sartor GC; Aston-Jones G
Physiol Behav; 2010 Jul; 100(5):419-28. PubMed ID: 20338186
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the orexin/hypocretin system in ethanol conditioned place preference.
Voorhees CM; Cunningham CL
Psychopharmacology (Berl); 2011 Apr; 214(4):805-18. PubMed ID: 21107540
[TBL] [Abstract][Full Text] [Related]
18. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization.
Sharf R; Guarnieri DJ; Taylor JR; DiLeone RJ
Brain Res; 2010 Mar; 1317():24-32. PubMed ID: 20034477
[TBL] [Abstract][Full Text] [Related]
19. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking.
Smith RJ; Aston-Jones G
Eur J Neurosci; 2012 Mar; 35(5):798-804. PubMed ID: 22356621
[TBL] [Abstract][Full Text] [Related]
20. Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat.
Watson SL; Watson CJ; Baghdoyan HA; Lydic R
J Pain; 2010 Jun; 11(6):535-44. PubMed ID: 20015707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
